Novartis Maalox one minute onset of action, not heartburn relief, is ad message, firm says.
This article was originally published in The Tan Sheet
Executive Summary
NOVARTIS MAALOX FASTER ONSET OF ACTION, NOT HEARTBURN RELIEF claim, is the message of the "One Minute Maalox" hospital ad challenged by Pepcid AC and Mylanta marketer J&J/Merck, Novartis asserts in a case report issued by the National Advertising Division of the Council of Better Business Bureaus April 6. The ad does not claim Maalox can relieve heartburn symptoms in one minute, Novartis says, but rather that its "onset of action" occurs in one minute. The commercial in question also does not state that hospitals choose Maalox solely because of faster onset of action, the company maintains.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning